Tad is a member of Reed Smith's Global Corporate Group and its Life Sciences Health Industry Group. His practice focuses on mergers and acquisitions, securities, corporate governance, general corporate and financing matters. He is experienced in counseling a wide range of clients, from early-stage companies to well-established, publicly traded companies. He has worked closely with the Boards of Directors of clients, their senior management and other personnel in pharmaceutical, biotechnology, medical device and other life sciences companies, as well as companies in the consumer products, information technology, software, telecommunications, and energy and natural resources industries.
- Rutgers, The State University of New Jersey School of Law, Newark, 1991, 法学博士, Recipient of the Justice Frederick Hall Award
- Hobart College, 1985, 学士, Economics
- American Bar Association
- New Jersey State Bar Association
- Listed as Highly Regarded in IFLR1000 United States for New Jersey M&A, 2018-2019. IFLR1000 United States is issued by IFLR1000. A description of the selection methodology can be found at iflr1000.com. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.